Overview
Gabapentin as an Adjunct to Paracervical Block for Perioperative Pain Management
Status:
Completed
Completed
Trial end date:
2018-06-26
2018-06-26
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
This is a randomized controlled trial of gabapentin 600 mg compared to placebo given 1-2 hours preoperatively in conjunction with perioperative paracervical block for surgical abortion. The researchers hypothesize that adding gabapentin to local anesthesia will reduce perioperative and postoperative pain associated with surgical abortion. Additionally, the researchers hypothesize that gabapentin will reduce nausea, vomiting, anxiety, and consumption of pain medication.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Emory UniversityCollaborator:
Society of Family PlanningTreatments:
Gabapentin
gamma-Aminobutyric Acid
Criteria
Inclusion Criteria:- Women >=18 years-old
- Presenting for a surgical abortion
- Fluency in English and able to provide informed consent
- Has a driver to take them home following the procedure
Exclusion Criteria:
- Allergy, sensitivity or contraindication to gabapentin
- Severe renal disease
- Currently using gabapentin or pregabalin
- Contraindication to outpatient abortion under local anesthesia